194 related articles for article (PubMed ID: 20146733)
1. Upper gastrointestinal endoscopic findings in the era of highly active antiretroviral therapy.
Nkuize M; De Wit S; Muls V; Arvanitakis M; Buset M
HIV Med; 2010 Jul; 11(6):412-7. PubMed ID: 20146733
[TBL] [Abstract][Full Text] [Related]
2. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy.
Mönkemüller KE; Call SA; Lazenby AJ; Wilcox CM
Am J Gastroenterol; 2000 Feb; 95(2):457-62. PubMed ID: 10685750
[TBL] [Abstract][Full Text] [Related]
3. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
Werneck-Silva AL; Prado IB
J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
[TBL] [Abstract][Full Text] [Related]
4. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
Pozio E
Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
[TBL] [Abstract][Full Text] [Related]
5. Effect of maintaining highly active antiretroviral therapy on AIDS events among patients with late-stage HIV infection and inadequate response to therapy.
Gandhi T; Wei W; Amin K; Kazanjian P
Clin Infect Dis; 2006 Mar; 42(6):878-84. PubMed ID: 16477568
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic infections and organ-specific diseases in HIV-1-infected children: a cohort study (1990-2006).
Guillén S; García San Miguel L; Resino S; Bellón JM; González I; Jiménez de Ory S; Muñoz-Fernández MA; Navarro ML; Gurbindo MD; de José MI; Mellado MJ; Martín-Fontelos P; Gonzalez-Tomé MI; Martinez J; Beceiro J; Roa MA; Ramos JT;
HIV Med; 2010 Apr; 11(4):245-52. PubMed ID: 20050937
[TBL] [Abstract][Full Text] [Related]
7. Effect of anti retroviral therapy (ART) on CD4 T lymphocyte count and the spectrum of opportunistic infections in HIV/AIDS in Manipur.
Chitra Y; Urgen S; Dayananda I; Brajachand SN
J Commun Dis; 2009 Mar; 41(1):19-24. PubMed ID: 19886171
[TBL] [Abstract][Full Text] [Related]
8. Opportunistic infections and other AIDS-defining illnesses in Poland in 2000-2002.
Podlasin RB; Wiercinska-Drapalo A; Olczak A; Beniowski M; Smiatacz T; Malolepsza E; Juszczyk J; Leszczyszyn-Pynka M; Mach T; Mian M; Knysz B; Horban A
Infection; 2006 Aug; 34(4):196-200. PubMed ID: 16896577
[TBL] [Abstract][Full Text] [Related]
9. [Effect of triple antiretroviral therapy on Tunisian AIDS profile: study of 139 cases].
Zouiten F; Ammari L; Goubantini A; Tiouiri H; Slim A; Maamouri A; Kilani B; Kanoun F; Marrakchi C; Neifer N; Mihoub L; Jenhani F; Garbouj M; Ben Chaabane T
Tunis Med; 2003 Dec; 81(12):956-62. PubMed ID: 14986532
[TBL] [Abstract][Full Text] [Related]
10. Immune restoration disorders following HAART.
Davaro RE; Himlan PH
AIDS Read; 1999; 9(3):167-9. PubMed ID: 12728901
[TBL] [Abstract][Full Text] [Related]
11. AIDS-defining opportunistic illnesses in US patients, 1994-2007: a cohort study.
Buchacz K; Baker RK; Palella FJ; Chmiel JS; Lichtenstein KA; Novak RM; Wood KC; Brooks JT;
AIDS; 2010 Jun; 24(10):1549-59. PubMed ID: 20502317
[TBL] [Abstract][Full Text] [Related]
12. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
13. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals.
Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ;
Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251
[TBL] [Abstract][Full Text] [Related]
14. Current status of opportunistic infections in patients with HIV infection in the era of highly active antiretroviral therapy.
Masur H; Kaplan J
Curr Clin Top Infect Dis; 2001; 21():64-82. PubMed ID: 11572162
[No Abstract] [Full Text] [Related]
15. [Impact of highly active antiretroviral therapy in the clinical, immunological and virological response from AIDS patients].
Reyes Corcho A; Mosquera Fernández MA; Bouza Jiménez Y; Pérez Avila J; Hernández V; Jam Morales B; Alvarez Amador G; Bouza Jiménez Y
Rev Cubana Med Trop; 2007; 59(2):139-48. PubMed ID: 23427448
[TBL] [Abstract][Full Text] [Related]
16. Opportunistic disorders of the gastrointestinal tract in the age of highly active antiretroviral therapy.
Huppmann AR; Orenstein JM
Hum Pathol; 2010 Dec; 41(12):1777-87. PubMed ID: 21078437
[TBL] [Abstract][Full Text] [Related]
17. Discontinuation of maintenance therapy for cryptococcal meningitis in patients with AIDS treated with highly active antiretroviral therapy: an international observational study.
Mussini C; Pezzotti P; Miró JM; Martinez E; de Quiros JC; Cinque P; Borghi V; Bedini A; Domingo P; Cahn P; Bossi P; de Luca A; d'Arminio Monforte A; Nelson M; Nwokolo N; Helou S; Negroni R; Jacchetti G; Antinori S; Lazzarin A; Cossarizza A; Esposito R; Antinori A; Aberg JA;
Clin Infect Dis; 2004 Feb; 38(4):565-71. PubMed ID: 14765351
[TBL] [Abstract][Full Text] [Related]
18. [Opportunistic diseases. Risk can be estimated].
Marquardt T; Jablonowski H
MMW Fortschr Med; 2003 Apr; 145 Spec No 1():33-7. PubMed ID: 15011582
[TBL] [Abstract][Full Text] [Related]
19. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
20. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
Viani RM; Araneta MR; Deville JG; Spector SA
Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
